News and Press Releases

Neutron Therapeutics Installs Europe’s First Accelerator-Based Boron Neutron Capture Therapy (BNCT) – On Track for First Cancer Patient Treatment in 2019

Thursday, 18th of April 2019 – Helsinki, Finland and Danvers MassachusettsNeutron Therapeutics, Inc (NTI) has installed its compact accelerator-based neutron source for Boron Neutron Capture Therapy (BNCT) at Helsinki University Hospital (HUH). The system is currently operational and generating neutron intensity at the level recommended by the IAEA for BNCT. The HUH installation is the first accelerator-based BNCT system in Europe and the first of its kind in the world. NTI is commissioning the neutron source for clinical use by the end of 2019.  > READ MORE


Yle News – Finland to Debut New High-powered Reactor for Cancer Treatments

Tuesday, 6th February 2018 – Helsinki, Finland. New Boron Neutron Capture Treatment in Helsinki, to be used to treat patients with recurring cancers of the head and neck. > READ MORE


HealthCare Business News – Neutron Therapeutics Partners with RaySearch Laboratories

Monday, 13th November 2017 – Danvers, MassachusettsNeutron Therapeutics partners with RaySearch Laboratories for Neutron’s revolutionary single-room BNCT solution. RaySearch to provide extended functionality offered by RayStation’s advanced treatment planning system.  > READ MORE


RaySearch Enters Into The Field Of Boron Neutron Capture Therapy

Monday, 6th November 2017 – Danvers, Massachusetts and Stockholm, Sweden.  RaySearch and Neutron Therapeutics, Inc., based in Danvers, US, have entered into an agreement regarding treatment planning for boron neutron capture therapy (BNCT), which is a unique type of radiation therapy that enables targeting of cancer at the cellular level.

BNCT uses a two-step process. First, the patient is injected with a tumor-localizing drug containing the non-radioactive isotope boron-10. In the second step, the target area is exposed to a beam of low-energy neutrons, many of which are absorbed by the boron-10. The absorption initiates a reaction in which short-range, high-energy charged particles are emitted. These particles systematically destroy the tumor cells, with minimal damage to adjacent healthy tissue. > READ MORE


Novel Accelerator-Based BNCT Suite to be Delivered to a top European Cancer Hospital

Thursday, 15th September, 2016 – Danvers, Massachusetts and Helsinki, Finland – Neutron Therapeutics, Inc (NTI) and Helsinki University Hospital (HUH) have entered into an arrangement whereby HUH Cancer Center acquires a nuBeam suite for boron-neutron capture therapy (BNCT). nuBeam is a compact accelerator based neutron source which can be installed in a hospital environment. Under the arrangement NTI and HUH will collaborate in developing BNCT towards clinical use in a number of cancer indications. A biologically targeted form of radiation therapy, BNCT has previously been applied by the HUH in the treatment of severe cancer cases using a research nuclear reactor as the neutron source.    > READ MORE


Revolutionary Cancer Treatment Engineered by Buckley Systems

Thursday, 15 September, 2016 – Auckland, New Zealand – Auckland precision electro magnets manufacturer, Buckley Systems is involved in the development and manufacture of the nuBeam proton accelerator machine for an alternative cancer treatment that has been announced overnight in Helsinki, Finland. Boron Neutron Capture Therapy is not a new treatment, but making it a practical proposition has only been possible as a result of co-operation between Buckley Systems and engineers who used to work for GT Advanced Technologies in Danvers, Massachusetts and a Helsinki medical team. A new company, Neutron Therapeutics, has been set up to make the technology viable as a compact, affordable and hospital ready source for a single neutron irradiation treatment.   > READ MORE